Home » Topics » BioWorld Science

BioWorld Science
RSS

TRUE CART therapy shows promise in solid tumors

March 10, 2022

SKLB-0322 shows potent antitumor activity in models of ovarian cancer

March 10, 2022

IRAK4 as immunotherapeutic target in pancreatic ductal adenocarcinoma

March 10, 2022

Viva Star Biosciences synthesizes new LPAR1 antagonists

March 10, 2022

Study casts new light on autoimmune disease etiology

March 10, 2022

Bolt Biotherapeutics presents new antibody-drug conjugates

March 10, 2022

Prelude Therapeutics identifies CDK9 inhibitors

March 10, 2022

Abbisko Therapeutics divulges new FGFR inhibitors

March 10, 2022

Aligos Therapeutics patents PRMT5 inhibitors

March 10, 2022

Modified B-cell peptide HER-Vaxx vaccine may limit breast cancer lung metastasis

March 10, 2022

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
Japan endorses two iPSC drugs for approval under CEA pathway
BioWorld
Japan is backing conditional approvals of Amchepry (raguneprocel, Sumitomo Pharma Co. Ltd./Racthera Co. Ltd.) and Reheart (Cuorips Inc.), positioning them to...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...